In new independent research reports released early this morning,
Capital Review released its latest key findings for all current
investors, traders, and shareholders of Amarin Corporation PLC
(NASDAQ:AMRN), PulteGroup, Inc. (NYSE:PHM), LivaNova PLC
(NASDAQ:LIVN), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA),
Viad Corp (NYSE:VVI), and Activision Blizzard, Inc (NASDAQ:ATVI),
including updated fundamental summaries, consolidated fiscal
reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
AMRN DOWNLOAD:
http://Capital-Review.com/register/?so=AMRN PHM DOWNLOAD:
http://Capital-Review.com/register/?so=PHM LIVN DOWNLOAD:
http://Capital-Review.com/register/?so=LIVN TEVA DOWNLOAD:
http://Capital-Review.com/register/?so=TEVA VVI DOWNLOAD:
http://Capital-Review.com/register/?so=VVI ATVI DOWNLOAD:
http://Capital-Review.com/register/?so=ATVI
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Capital Review,
available for free download at the links above, examine Amarin
Corporation PLC (NASDAQ:AMRN), PulteGroup, Inc. (NYSE:PHM),
LivaNova PLC (NASDAQ:LIVN), Teva Pharmaceutical Industries Ltd.
(NYSE:TEVA), Viad Corp (NYSE:VVI), and Activision Blizzard, Inc
(NASDAQ:ATVI) on a fundamental level and outlines the overall
demand for their products and services in addition to an in-depth
review of the business strategy, management discussion, and overall
direction going forward. Several excerpts from the recently
released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. All information in
this release was accessed March 4th, 2019. Percentage calculations
are performed after rounding. All amounts in millions (MM), except
per share amounts.
-----------------------------------------
AMARIN CORPORATION PLC (AMRN) REPORT
OVERVIEW
Amarin's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Amarin reported revenue of $77.33MM vs
$53.87MM (up 43.56%) and analysts estimated basic earnings per
share -$0.11 vs -$0.08. For the twelve months ended December 31st,
2018 vs December 31st, 2017, Amarin reported revenue of $229.21MM
vs $181.10MM (up 26.56%) and analysts estimated basic earnings per
share -$0.39 vs -$0.25. Analysts expect earnings to be released on
May 1st, 2019. The report will be for the fiscal period ending
March 31st, 2019. The reported EPS for the same quarter last year
was -$0.08. The estimated EPS forecast for the next fiscal year is
$0.25 and is expected to report on February 26th, 2020.
To read the full Amarin Corporation PLC (AMRN) report, download
it here:
http://Capital-Review.com/register/?so=AMRN
-----------------------------------------
PULTEGROUP, INC. (PHM) REPORT OVERVIEW
PulteGroup's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, PulteGroup reported revenue of $2,999.15MM
vs $2,794.89MM (up 7.31%) and analysts estimated basic earnings per
share $0.84 vs $0.25 (up 236.00%). For the twelve months ended
December 31st, 2018 vs December 31st, 2017, PulteGroup reported
revenue of $10,188.33MM vs $8,577.69MM (up 18.78%) and analysts
estimated basic earnings per share $3.56 vs $1.45 (up 145.52%).
Analysts expect earnings to be released on April 23rd, 2019. The
report will be for the fiscal period ending March 31st, 2019.
Reported EPS for the same quarter last year was $0.59. The
estimated EPS forecast for the next fiscal year is $3.32 and is
expected to report on February 4th, 2020.
To read the full PulteGroup, Inc. (PHM) report, download it
here:
http://Capital-Review.com/register/?so=PHM
-----------------------------------------
LIVANOVA PLC (LIVN) REPORT OVERVIEW
LivaNova's Recent Financial Performance
For the three months ended September 30th, 2018
vs September 30th, 2017, LivaNova reported revenue of $272.08MM vs
$251.25MM (up 8.29%) and analysts estimated basic earnings per
share -$0.15 vs $0.58. For the twelve months ended December 31st,
2017 vs December 31st, 2016, LivaNova reported revenue of
$1,012.28MM vs $964.86MM (up 4.91%) and analysts estimated basic
earnings per share -$0.52 vs -$1.29. Analysts expect earnings to be
released on May 1st, 2019. The report will be for the fiscal period
ending March 31st, 2019. Reported EPS for the same quarter last
year was $0.36. The estimated EPS forecast for the next fiscal year
is $3.62 and is expected to report on February 26th, 2020.
To read the full LivaNova PLC (LIVN) report, download it here:
http://Capital-Review.com/register/?so=LIVN
-----------------------------------------
TEVA PHARMACEUTICAL INDUSTRIES LTD. (TEVA) REPORT
OVERVIEW
Teva Pharmaceutical Industries' Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Teva Pharmaceutical Industries reported
revenue of $4,559.00MM vs $5,398.00MM (down 15.54%) and basic
earnings per share -$2.88 vs -$11.41. For the twelve months ended
December 31st, 2018 vs December 31st, 2017, Teva Pharmaceutical
Industries reported revenue of $18,854.00MM vs $22,385.00MM (down
15.77%) and analysts estimated basic earnings per share -$2.35 vs
-$16.26. Analysts expect earnings to be released on May 2nd, 2019.
The report will be for the fiscal period ending March 31st, 2019.
The reported EPS for the same quarter last year was $0.91. The
estimated EPS forecast for the next fiscal year is $2.56 and is
expected to report on February 12th, 2020.
To read the full Teva Pharmaceutical Industries Ltd. (TEVA)
report, download it here:
http://Capital-Review.com/register/?so=TEVA
-----------------------------------------
VIAD CORP (VVI) REPORT OVERVIEW
Viad's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Viad reported revenue of $296.92MM vs
$277.29MM (up 7.08%) and analysts estimated basic earnings per
share -$0.12 vs -$1.06. For the twelve months ended December 31st,
2018 vs December 31st, 2017, Viad reported revenue of $1,296.18MM
vs $1,306.97MM (down 0.82%) and analysts estimated basic earnings
per share $2.40 vs $2.83 (down 15.19%). Analysts expect earnings to
be released on April 25th, 2019. The report will be for the fiscal
period ending March 31st, 2019. The reported EPS for the same
quarter last year was -$0.49. The estimated EPS forecast for the
next fiscal year is $3.55 and is expected to report on February
6th, 2020.
To read the full Viad Corp (VVI) report, download it here:
http://Capital-Review.com/register/?so=VVI
-----------------------------------------
ACTIVISION BLIZZARD, INC (ATVI) REPORT
OVERVIEW
Activision Blizzard's Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Activision Blizzard reported revenue of
$2,382.00MM vs $2,042.00MM (up 16.65%) and analysts estimated basic
earnings per share $0.85 vs -$0.78. For the twelve months ended
December 31st, 2018 vs December 31st, 2017, Activision Blizzard
reported revenue of $7,500.00MM vs $7,017.00MM (up 6.88%) and
analysts estimated basic earnings per share $2.38 vs $0.36 (up
561.11%). Analysts expect earnings to be released on May 2nd, 2019.
The report will be for the fiscal period ending March 31st, 2019.
The reported EPS for the same quarter last year was $0.34. The
estimated EPS forecast for the next fiscal year is $2.59 and is
expected to report on February 11th, 2020.
To read the full Activision Blizzard, Inc (ATVI) report,
download it here:
http://Capital-Review.com/register/?so=ATVI
-----------------------------------------
ABOUT CAPITAL REVIEW
Capital Review is a nationally recognized
publisher of financial analysis, research reports, and exclusive
market reporting. Institutional investors, registered brokers,
professional traders, and personal investment advisers rely on
Capital Review to quantify public company valuations, discover
opportunity across asset classes, stay informed about market-moving
events, and read exclusive analysis of important material
developments. With 14 offices worldwide, Capital Review staffs and
manages certified and registered financial professionals, including
Chartered Financial Analyst® (CFA®) designation holders and FINRA®
BrokerCheck® certified individuals with current and valid CRD®
number designations, to enable continuous coverage of topics
relevant to its regular active reader base.
REGISTERED MEMBER STATUS
Capital Review's oversight and audit staff are
registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Capital Review's roster includes qualified
CFA® charterholders, licensed securities attorneys, and registered
FINRA® members holding duly issued CRD® numbers. Current licensed
status of several Registered Members at Capital Review have been
independently verified by an outside audit firm, including policy
and audit records duly executed by Registered Members. Complaints,
concerns, questions, or inquiries regarding this release should be
directed to Capital Review's Compliance department by Phone, at +1
(410) 280-7496, or by E-mail at compliance@Capital-Review.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Capital Review,
Capital Review members, and/or Capital Review affiliates are not
responsible for any gains or losses that result from the opinions
expressed. Capital Review makes no representations as to the
completeness, accuracy, or timeliness of the material provided and
all materials are subject to change without notice. Capital Review
has not been compensated for the publication of this press release
by any of the above mentioned companies. Capital Review is not a
financial advisory firm, investment adviser, or broker-dealer, and
does not undertake any activities that would require such
registration. For our full disclaimer, disclosure, and terms of
service please visit our website.
Media Contact: Nicole Garrens, Media Department
Office: +1 (410) 280-7496 E-mail: media@Capital-Review.com
© 2019 Capital Review. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@Capital-Review.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024